Quality

QA for Digital Systems & Emerging Technologies

Quality assurance for digital systems and emerging technologies governs how software, automation, and connected tools are introduced and maintained in GxP environments. Clinical apps, eSource platform…

Practice areaQuality
Typical needCapability support for regulated programs
EngagementConsulting, augmentation, or hybrid
Related pathQuality

Quality assurance for digital systems and emerging technologies governs how software, automation, and connected tools are introduced and maintained in GxP environments. Clinical apps, eSource platforms, manufacturing analytics, AI-assisted review tools, and digital quality management modules all create new control and data integrity questions for FDA-regulated work. Viltis helps quality teams set practical oversight so digital adoption does not outrun validation, change control, and SOP ownership.

Digital tools often arrive through business units before quality has a clear intended-use statement. That gap leads to shadow IT, incomplete Part 11 assessments, and unclear responsibility when something fails in a regulated workflow. Our consultants help define when a tool is GxP-relevant, what risk assessment is required, and how vendor claims should be challenged with configuration evidence. Oversight covers implementation, release, ongoing monitoring, and retirement so the full lifecycle stays visible to the quality unit.

Emerging technologies add specific concerns: model drift for analytics, continuous cloud vendor updates, interface failures that corrupt records, and training gaps when workflows change faster than SOPs. QA oversight should require documented intended use, validation or qualification proportionate to risk, audit trail review where applicable, and CAPA pathways when digital defects affect GxP decisions. We work with IT, validation, and process owners so quality requirements are written in language engineers and operators can execute without guesswork.

Viltis provides QA consulting and embedded resources for digital GxP programs. We do not issue regulatory certificates or product certifications for software vendors or sponsors. The aim is clear governance your inspection team can explain: what the system does, how it was controlled at go-live, and how changes stay within the validated or qualified state under your SOPs and change control.

Quality oversight for digital systems commonly addresses

  • GxP relevance and risk assessment for new digital tools
  • Alignment of CSV, CQV, and quality controls for software
  • Vendor assessment and SaaS change-notification handling
  • SOP, training, and access control updates for new workflows
  • Audit trail and data integrity checks for digital records
  • Ongoing monitoring, CAPA, and periodic review support

If digital initiatives are moving faster than your quality procedures, early QA involvement prevents expensive rework after go-live or after an FDA finding. Contact Viltis to discuss oversight for the systems and technologies on your near-term roadmap and release plan.

Related proof

Biologics CMC PIP

CMC and quality oversight for a Phase III monoclonal antibody program at a CMO.

Read the case study →

Viltis provides consulting and resourcing for compliance readiness and operational support. We do not issue certifications or act as an accredited certification body.

Need support with QA for Digital Systems & Emerging Technologies?

Discuss this requirement with our team - scope, timeline, and delivery model.